Completed NA INTERVENTIONAL 2-arm
NCT05447065
Impact of Vitamin D Supplementation on COVID-19 Vaccine Response and IgG Antibodies in Deficient Women. (CoVıD-19)
Sponsor: Avrasya University
Interventions
Vitamin D supplement
Updated 4 times since 2022 Last updated: Sep 26, 2022 Started: May 7, 2022 Primary completion: Jun 10, 2022 Completion: Jul 7, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A NA clinical study on Antibody Hypersensitivity and COVID-19 Pandemic, this trial is completed. The trial is conducted by Avrasya University and has accumulated 4 data snapshots since 2022. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
4 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2022 — Jul 2024 [monthly]
Completed NA
First recorded
May 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Avrasya University
- Ege University
Data source: Ege University
For direct contact, visit the study record on ClinicalTrials.gov .